Hotchkiss J A, Kim S G, Novak R F, Dahl A R
Inhalation Toxicology Research Institute, Lovelace Biomedical Environmental Research Institute, Albuquerque, New Mexico 87185.
Toxicol Appl Pharmacol. 1993 Jan;118(1):98-104. doi: 10.1006/taap.1993.1014.
Previous research has shown that intraperitoneal injection of the solvent pyridine results in a dose- and time-dependent induction of hepatic P450IIE1 in rats, with a twofold increase observed at 6 hr post-treatment. However, inhalation is the primary route of exposure expected for humans exposed to pyridine in laboratory and industrial settings or in tobacco smoke. In view of the potency and rapidity of induction associated with pyridine treatment, research was initiated to examine whether inhalation of the solvent at the current threshold limit value level of 5 ppm or at an elevated level of 440 ppm resulted in sufficient nasal and pulmonary uptake and systemic redistribution to cause increased hepatic expression of rat cytochrome P450IIE1. Rats were exposed, 6 hr/day, to 5 ppm pyridine for 4 days; to 440 ppm pyridine for 1 or 4 days; or to filtered air for 1 or 4 days. Rats were sacrificed 18 hr after the last exposure. Liver samples were taken from the air- and pyridine-exposed rats. Expression of immunoreactive P450IIE1 was examined in tissue sections using immunohistochemistry and in microsomal preparations using Western blot analyses. Hepatic tissue obtained from rats exposed to 5 ppm pyridine for 4 days or to 440 ppm pyridine for 1 or 4 days displayed significantly elevated levels of immunoreactive P450IIE1. Immunohistochemical analyses of liver sections showed that inhalation of pyridine at 5 ppm resulted in an elevated expression of P450IIE1 in hepatocytes surrounding terminal hepatic venules (THVs). Exposure to 440 ppm pyridine caused both increased expression of IIE1 in hepatocytes surrounding THVs after a single 6-hr exposure and an approximately three- to fourfold increase in the total number of cells expressing IIE1 after 4 days of exposure. Dilution analysis of immunohistochemically stained tissue revealed a significant difference between air-exposed controls and pyridine-exposed rats, at all exposure levels. P450IIE1 levels in microsomes isolated from rats receiving 5 and 440 ppm pyridine for 4 days were increased 2.5- and 10-fold as judged from scanning laser densitometry. This study reveals that inhalation of pyridine vapors at levels equal to or greater than the current threshold limit value of 5 ppm results in significant hepatic induction of P450IIE1 in rats.
先前的研究表明,腹腔注射溶剂吡啶会使大鼠肝脏中的P450IIE1呈剂量和时间依赖性诱导,在处理后6小时观察到其增加了两倍。然而,吸入是在实验室、工业环境或烟草烟雾中接触吡啶的人类预期的主要暴露途径。鉴于与吡啶处理相关的诱导效力和速度,开展了研究以检查吸入当前阈限值水平5 ppm或升高水平440 ppm的该溶剂是否会导致足够的鼻腔和肺部摄取以及全身再分布,从而引起大鼠细胞色素P450IIE1的肝脏表达增加。将大鼠每天暴露6小时,使其暴露于5 ppm吡啶中4天;暴露于440 ppm吡啶中1天或4天;或暴露于过滤空气中1天或4天。在最后一次暴露后18小时处死大鼠。从暴露于空气和吡啶的大鼠中采集肝脏样本。使用免疫组织化学在组织切片中以及使用蛋白质印迹分析在微粒体制剂中检查免疫反应性P450IIE1的表达。从暴露于5 ppm吡啶4天或暴露于440 ppm吡啶1天或4天的大鼠获得的肝组织显示免疫反应性P450IIE1水平显著升高。肝脏切片的免疫组织化学分析表明,吸入5 ppm吡啶会导致终末肝小静脉(THV)周围肝细胞中P450IIE1的表达升高。暴露于440 ppm吡啶在单次6小时暴露后导致THV周围肝细胞中IIE1表达增加,并且在暴露4天后表达IIE1的细胞总数增加约三至四倍。对免疫组织化学染色组织的稀释分析显示,在所有暴露水平下,暴露于空气的对照大鼠与暴露于吡啶的大鼠之间存在显著差异。根据扫描激光密度测定法判断,从接受5 ppm和440 ppm吡啶4天的大鼠中分离出的微粒体中P450IIE1水平分别增加了2.5倍和10倍。这项研究表明,吸入等于或高于当前阈限值5 ppm的吡啶蒸气会导致大鼠肝脏中P450IIE1的显著诱导。